Functional Recovery in Autoimmune Encephalitis: A Prospective Observational Study.
Abstract | Background: Methods: Adult patients with a diagnosis of autoimmune encephalitis were included into a prospective registry. At 3, 6 and 12 months of follow-up, the patients' modified Rankin Scale (mRS) was obtained. Results: Patients were stratified into three groups according to their antibody (Ab) status: anti-NMDAR-Ab (n=12; group I), anti-LGI1/CASPR2-Ab (n=35; group II), and other antibodies (n=24; group III). A comparably higher proportion of patients in group I received plasma exchange/immunoadsorption and second line immunosuppressive treatments at baseline. A higher proportion of patients in group II presented with seizures. Group III mainly included patients with anti-GABABR-, anti-GAD65- and anti-GlyR-Ab. At baseline, one third of them had cancer. Patients in groups I and III had much higher median mRS scores at 3 months compared to patients in group II. A median mRS of 1 was found at all follow-up time points in group II. Conclusions: The different dynamics in the recovery of patients with certain autoimmune encephalitides have important implications for clinical trials. The high proportion of patients with significant disability at 3 months after diagnosis in groups I and III points to the need for improving treatment options. More distinct scores rather than the mRS are necessary to differentiate potential neurological improvements in patients with anti-LGI1-/CASPR2- encephalitis.
|
Authors | Thomas Seifert-Held, Katharina Eberhard, Christian Lechner, Stefan Macher, Harald Hegen, Tobias Moser, Gregor Brecl Jacob, Gertraud Puttinger, Raffi Topakian, Michael Guger, Emrah Kacar, Lea Zoche, Desiree De Simoni, Andreas Seiser, Stefan Oberndorfer, Christoph Baumgartner, Walter Struhal, Friedrich Zimprich, Johann Sellner, Florian Deisenhammer, Christian Enzinger, Markus Reindl, Helmut Rauschka, Thomas Berger, Romana Höftberger |
Journal | Frontiers in immunology
(Front Immunol)
Vol. 12
Pg. 641106
( 2021)
ISSN: 1664-3224 [Electronic] Switzerland |
PMID | 34093529
(Publication Type: Journal Article, Observational Study, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2021 Seifert-Held, Eberhard, Lechner, Macher, Hegen, Moser, Jacob, Puttinger, Topakian, Guger, Kacar, Zoche, De Simoni, Seiser, Oberndorfer, Baumgartner, Struhal, Zimprich, Sellner, Deisenhammer, Enzinger, Reindl, Rauschka, Berger and Höftberger. |
Topics |
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Autoimmune Diseases of the Nervous System
(immunology)
- Encephalitis
(immunology)
- Female
- Humans
- Male
- Middle Aged
- Prospective Studies
- Recovery of Function
- Young Adult
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|